Tag: Avelumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Avelumab

4D Pharma reveals progress in phase 2 trial of live biotherapeutic candidate in bladder cancer

Added to Collection on: 2022-05-27 16:34:50

Tags for this article:

Clinical medicine
Cancer treatments
Medicine
Cancer immunotherapy
Breakthrough therapy
Orphan drugs
Immune system
Avelumab
Checkpoint inhibitor
Pembrolizumab
Renal cell carcinoma
Transitional cell carcinoma
Duncan Peyton

Click the tags to see associated articles and topics

View Article Details
Avelumab first-line maintenance linked to long-term OS benefit in UC regardless of receipt of ...

Added to Collection on: 2022-06-04 20:56:15

Tags for this article:

Cancer
Breakthrough therapy
Orphan drugs
Drugs
Health sciences
Avelumab
Transitional cell carcinoma
Bladder cancer
Transitional epithelium

Click the tags to see associated articles and topics

View Article Details
Paris Court of Appeal reverses case law in Dana Faber vs. INPI - JUVE Patent

Added to Collection on: 2022-06-10 09:17:50

Tags for this article:

Patent law of the European Union
Avelumab
Breakthrough therapy
Supplementary protection certificate
Drugs
Patent office
Patent attorney
INPI
Patent
Health sciences
Health care

Click the tags to see associated articles and topics

View Article Details
Immutep in clinical trail collaboration with Merck KGaA and Pfizer - PharmaTimes

Added to Collection on: 2022-11-29 16:59:05

Tags for this article:

Health
Cancer
Clinical medicine
Avelumab
Breakthrough therapy
Merck
Transitional epithelium
Eftilagimod alpha
Transitional cell carcinoma
Merck Group
Immutep
Bladder cancer
Germany
Pfizer
Darmstadt
Merck KGaA

Click the tags to see associated articles and topics

View Article Details
Immutep Enters Clinical Trial Collaboration Merck KGaA And Pfizer | Contract Pharma

Added to Collection on: 2022-11-29 16:14:44

Tags for this article:

Health
Clinical medicine
Medicine
Cancer treatments
Avelumab
Breakthrough therapy
Merck
Eftilagimod alpha
Immutep
Transitional epithelium
Checkpoint inhibitor
Merck Group
Germany
Pfizer
Merck KGaA

Click the tags to see associated articles and topics

View Article Details
Pfizer, Merck KGaA join Immutep in Phase 1 trial for kidney cancer therapy - Seeking Alpha

Added to Collection on: 2022-11-29 13:39:14

Tags for this article:

Health
Drugs
Breakthrough therapy
Merck
Avelumab
Immutep
Merck Group
Pfizer
Transitional cell carcinoma
PD-1 and PD-L1 inhibitors
Merck KGaA
Immutep Limited

Click the tags to see associated articles and topics

View Article Details
Immutep in second collaborative oncology trial with Merck and Pfizer - BioPharma-Reporter

Added to Collection on: 2022-12-05 23:32:13

Tags for this article:

Medicine
Clinical medicine
Health
Immune system
Breakthrough therapy
Merck
Orphan drugs
Avelumab
Eftilagimod alpha
PD-L1
Immutep
LAG3
Pfizer Inc.
Merck KGaA

Click the tags to see associated articles and topics

View Article Details
FDA Approves Encorafenib Plus Binimetinib Combination for Non-Small Cell Lung Cancer

Added to Collection on: 2023-10-12 17:07:50

Tags for this article:

Orphan drugs
Cancer treatments
Encorafenib
MEK inhibitor
Binimetinib
Melanoma
BRAF
Non-small-cell lung cancer
Brain metastasis
Avelumab
Dabrafenib

Click the tags to see associated articles and topics

View Article Details
Merkel Cell Carcinoma Treatment Market is Expected to Reach the Valuation of USD 4.39 ...

Added to Collection on: 2023-11-08 19:19:31

Tags for this article:

Breakthrough therapy
Orphan drugs
Merkel-cell carcinoma
Angela Merkel
Skin cancer
Merkel cell
Avelumab
Pharmaceutical industry in China
Cancer

Click the tags to see associated articles and topics

View Article Details
Tumor biology may affect response to kidney cancer treatment, study finds - Urology Times

Added to Collection on: 2024-02-26 19:52:33

Tags for this article:

Orphan drugs
Avelumab
Sunitinib
Renal cell carcinoma
Kidney cancer
PD-1 and PD-L1 inhibitors
Cancer treatment
Axitinib

Click the tags to see associated articles and topics

View Article Details